相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Plasma Levels of CGRP During a 2-h Infusion of VIP in Healthy Volunteers and Patients With Migraine: An Exploratory Study
Lanfranco Pellesi et al.
FRONTIERS IN NEUROLOGY (2022)
The effect of pituitary adenylate cyclase-activating peptide-38 and vasoactive intestinal peptide in cluster headache
Anne Luise H. Vollesen et al.
CEPHALALGIA (2020)
Calcitonin-gene related peptide and disease activity in cluster headache
Agneta Snoer et al.
CEPHALALGIA (2019)
PACAP and its role in primary headaches
Lars Edvinsson et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Cluster headache
Arne May et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients
Song Guo et al.
CEPHALALGIA (2017)
STIMULATORY EFFECT OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE 6-38, M65 AND VASOACTIVE INTESTINAL POLYPEPTIDE 6-28 ON TRIGEMINAL SENSORY NEURONS
E. Saghy et al.
NEUROSCIENCE (2015)
The International Classification of Headache Disorders, 3rd edition (beta version)
Andre Bes et al.
CEPHALALGIA (2013)
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase- activating polypeptide (PACAP) in the circulation after sumatriptan
Jakob Moller Hansen et al.
SCANDINAVIAN JOURNAL OF PAIN (2013)
Pituitary adelylate cyclase-activating peptide is an activator of vasoactive intestinal polypeptide gene transcription in human neuroblastoma cells
B Georg et al.
MOLECULAR BRAIN RESEARCH (2000)
分享论文
